Dipeptide Frequency of Word Frequency and Graph Convolutional Networks for DTA Prediction

Deep learning is an effective method to capture drug-target binding affinity, but low accuracy is still an obstacle to be overcome. Thus, we propose a novel predictor for drug-target binding affinity based on dipeptide frequency of word frequency encoding and a hybrid graph convolutional network. Word frequency characteristics of natural language are used to improve the frequency characteristics of peptides to express target proteins. For each drug molecules, the five different features of drug atoms and the atomic bond relationships are expressed as graphs. The obtained protein features and graph structure are used as the input of convolution neural network and the input of graph convolution neural network, respectively. A prediction model is established to predict the drug affinity by calculating the hidden relationship. In the KIBA data set test experiment, the consistency coefficient of the model is 0.901, which is 0.01 higher than the existing model, and the MSE (mean square error) of the model is 0.126, which is 5% lower than the existing model. In Davis data set test experiment, the consistency coefficient of the model is 0.895, which is 0.006 higher than the existing model, and the MSE of the model is 0.220, which is 4% lower than the existing model. These results show that our proposed method can not only predict the affinity better than those existing models, but also outperform unitary deep learning approaches.

[1]  Max Welling,et al.  Semi-Supervised Classification with Graph Convolutional Networks , 2016, ICLR.

[2]  Hojung Nam,et al.  SELF-BLM: Prediction of drug-target interactions via self-training SVM , 2017, PloS one.

[3]  James L. McClelland,et al.  Quasi-compositional mapping from form to meaning: a neural network-based approach to capturing neural responses during human language comprehension , 2019, Philosophical Transactions of the Royal Society B.

[4]  P. Cohen.  Protein kinases — the major drug targets of the twenty-first century? , 2002, Nature reviews. Drug discovery.

[5]  Tudor I. Oprea,et al.  Drug Repurposing: Far Beyond New Targets for Old Drugs , 2012, The AAPS Journal.

[6]  Tudor I. Oprea,et al.  A comprehensive map of molecular drug targets , 2016, Nature Reviews Drug Discovery.

[7]  Regina Z. Cer,et al.  IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding , 2009, Nucleic Acids Res..

[8]  Raghvendra Mall,et al.  PaRSnIP: sequence-based protein solubility prediction using gradient boosting machine , 2018, Bioinform..

[9]  Tao Xu,et al.  Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis , 2014, J. Chem. Inf. Model..

[10]  L. Johnson,et al.  Protein Kinase Inhibitors: Insights into Drug Design from Structure , 2004, Science.

[11]  Achim Zeileis,et al.  Bias in random forest variable importance measures: Illustrations, sources and a solution , 2007, BMC Bioinformatics.

[12]  Allen D. Roses,et al.  Pharmacogenetics in drug discovery and development: a translational perspective , 2008, Nature Reviews Drug Discovery.

[13]  Mary G. George,et al.  Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study , 2017, BMJ Open.

[14]  Raghvendra Mall,et al.  DeepSol: a deep learning framework for sequence‐based protein solubility prediction , 2018, Bioinform..

[15]  Xiao-Ying Yan,et al.  Prediction of drug-target interaction by integrating diverse heterogeneous information source with multiple kernel learning and clustering methods , 2019, Comput. Biol. Chem..

[16]  Jun Sun,et al.  Development of deep learning method for lead content prediction of lettuce leaf using hyperspectral images , 2019, International Journal of Remote Sensing.

[17]  Jatinderkumar R. Saini,et al.  Designing punjabi poetry classifiers using machine learning and different textual features , 2019, Int. Arab J. Inf. Technol..

[18]  Yu-Yen Ou,et al.  DeepETC: A deep convolutional neural network architecture for investigating and classifying electron transport chain's complexes , 2020, Neurocomputing.

[19]  Weida Tong,et al.  In silico drug repositioning: what we need to know. , 2013, Drug discovery today.

[20]  Loris Nanni,et al.  iProStruct2D: Identifying protein structural classes by deep learning via 2D representations , 2019, Expert Syst. Appl..

[21]  Jure Leskovec,et al.  How Powerful are Graph Neural Networks? , 2018, ICLR.

[22]  Tapani Raiko,et al.  International Conference on Learning Representations (ICLR) , 2016 .

[23]  Yutaka Akiyama,et al.  NRLMFβ: Beta-distribution-rescored neighborhood regularized logistic matrix factorization for improving the performance of drug–target interaction prediction , 2019, Biochemistry and biophysics reports.

[24]  Artem Cherkasov,et al.  SimBoost: a read-across approach for predicting drug–target binding affinities using gradient boosting machines , 2017, Journal of Cheminformatics.

[25]  Mariana Belgiu,et al.  Random forest in remote sensing: A review of applications and future directions , 2016 .

[26]  Zhu-Hong You,et al.  RFDT: A Rotation Forest-based Predictor for Predicting Drug-Target Interactions Using Drug Structure and Protein Sequence Information. , 2016, Current protein & peptide science.

[27]  Pietro Liò,et al.  Graph Attention Networks , 2017, ICLR.

[28]  M. Köppen,et al.  The Curse of Dimensionality , 2010 .

[29]  Vladimir B. Bajic,et al.  DDR: efficient computational method to predict drug–target interactions using graph mining and machine learning approaches , 2017, Bioinform..

[30]  Yi Xiong,et al.  DTI-CDF: a cascade deep forest model towards the prediction of drug-target interactions based on hybrid features , 2019, Briefings Bioinform..

[31]  Chee-Keong Kwoh,et al.  Computational prediction of drug-target interactions using chemogenomic approaches: an empirical survey , 2019, Briefings Bioinform..

[32]  Arzucan Özgür,et al.  DeepDTA: deep drug–target binding affinity prediction , 2018, Bioinform..

[33]  Mindy I. Davis,et al.  Comprehensive analysis of kinase inhibitor selectivity , 2011, Nature Biotechnology.